Hemodynamic effects by glucagon-like peptide-1 receptor analogues : What should be measured?
(2017) In Journal of Hypertension 35(5). p.953-954
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/c754dd36-fdfc-4754-bd8e-f4b1780a4ada
- author
- Nilsson, Peter M. LU
- organization
- publishing date
- 2017
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Hypertension
- volume
- 35
- issue
- 5
- pages
- 953 - 954
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- scopus:85017335775
- pmid:28353547
- wos:000401265800007
- ISSN
- 0263-6352
- DOI
- 10.1097/HJH.0000000000001315
- language
- English
- LU publication?
- yes
- id
- c754dd36-fdfc-4754-bd8e-f4b1780a4ada
- date added to LUP
- 2017-05-04 17:04:59
- date last changed
- 2025-04-04 14:20:16
@misc{c754dd36-fdfc-4754-bd8e-f4b1780a4ada,
author = {{Nilsson, Peter M.}},
issn = {{0263-6352}},
language = {{eng}},
number = {{5}},
pages = {{953--954}},
publisher = {{Lippincott Williams & Wilkins}},
series = {{Journal of Hypertension}},
title = {{Hemodynamic effects by glucagon-like peptide-1 receptor analogues : What should be measured?}},
url = {{http://dx.doi.org/10.1097/HJH.0000000000001315}},
doi = {{10.1097/HJH.0000000000001315}},
volume = {{35}},
year = {{2017}},
}